We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
Date | Subject | Author | Discuss |
---|---|---|---|
05/2/2018 15:24 | Given the earnings forecast and fact the share price was already relatively low compared to its peers the recent daily price drop is quite surprising (even allowing for the current market (2 day) 'downturn'). GSK appear to have a solid product base and stable outlook which is better than many many other large companies at the moment but time will tell. | afed1 | |
05/2/2018 15:19 | Added more @ 1276p which is support, it may hold. Anyway added to the long term holdings, nice quarterly divi payer | ny boy | |
05/2/2018 14:56 | Hopefully up big time Wednesday if this happens. | montyhedge | |
05/2/2018 14:30 | Figures on Wednesday, 23p dividend will be paid for this quarter, not to bad. | montyhedge | |
05/2/2018 14:30 | Investors think if we win bid, dividend will be cut. | montyhedge | |
05/2/2018 14:13 | Wood Be careful, put in our bid along with Reckitt for Pfizer division, see what the outcome is, see who wins. | montyhedge | |
05/2/2018 13:32 | Quarterly results on Wednesday and then ex-divi in 2 weeks time. Think a top up might be in order while the sales are on. | woodhawk | |
05/2/2018 12:48 | Just as well I live in a bungalow... | 2hoggy | |
05/2/2018 12:40 | No, but 10%-15% fall still to come on Dow, we have had 5% fall in a week. | montyhedge | |
05/2/2018 12:37 | Will there be a replay of the 1929,jumping out of the windows and stuff ! | abdullla | |
05/2/2018 12:36 | I'm sure there will be a time to top up - but I don't think it's now | hosede | |
05/2/2018 12:32 | Risk off Dow futures looking ugly again for today. | montyhedge | |
05/2/2018 12:16 | I seen people say here that these share price drops were bargains so why complain start topping up and be grateful ! | abdullla | |
05/2/2018 11:52 | Yes It's equally amazing that Cos. always buy back their own shares near the top | hosede | |
05/2/2018 11:46 | Probably appointed so they can appear or so PC. This has enough debt as it is. Are they after even more gearing . Making the mistake many execs seem to make at stock market highs. They go on the hunt for aquisitions. Why not buy when assett prices are low. Pfizer are smarter being the sellers. Seen it countless times. Stupid woman. imho | pineapple1 | |
05/2/2018 11:24 | This wretched woman leading this company is destroying value by the day, she should scupper any talk of buying Pfizer’s consumer healthcare division, it is not going to bring any value here, she should be focusing on the mess left by Whitty, raising the debt and leaving the dividend uncovered. It was a mistake to appoint her, they should have appointed an outsider, best hope for shareholders is that this gets taken over itself! | wormhasturned | |
05/2/2018 11:02 | The good, bad and ugly all getting hit today. | montyhedge | |
05/2/2018 08:22 | Full-year sales at Pfizer Consumer Healthcare unit advanced by just 2 percent to $3.47 billion. A $15-20 billion price tag seems demanding as there's nowhere near enough margin to cover the outlay. Also, online sales (e.g. Amazon) of competing products (e.g. vs Centrum) are eroding this 'me-too' business. | tradermichael | |
04/2/2018 20:52 | GSK set for record sales as Emma Walmsley fires up drugs pipeline | kamitora | |
04/2/2018 14:17 | Glaxo, Reckitt Submit Only Bids for Pfizer's Consumer UnitManuel Baigorri, James Paton, Jared S Hopkins, Ruth DavidManuel Baigorri, James Paton, Jared S Hopkins, Ruth DavidBloombergFebrua | mj19 | |
04/2/2018 09:16 | I'm not expecting a beat, but 23p dividend. If they did beat, could have take off in the share price. | montyhedge | |
02/2/2018 20:54 | 'Is a Beat in the Cards for Glaxo (GSK) This Earnings Season?' We expect GlaxoSmithKline plc GSK to beat expectations when it reports fourth-quarter 2017 results on Feb 7... | philanderer | |
02/2/2018 18:07 | It's about time there was some profit taking TBH. DOW had risen over 25% in 12 months. I thought it would happen a few thousand points ago and closed my longs. In a corrective market then GSK should do relatively better as a defensive. That does not mean it will go up, just fare better than the average. | polaris |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions